Recently, the Ministry of Industry and Information Technology released the fourth batch of "specialized and special new" enterprises public list, Dongtai Pharmaceutical after declaration and review, from many participating enterprises stood out, successfully listed. The "national level

The successful selection of "specialized new enterprise" is the recognition and encouragement of the National Ministry of Finance and the Ministry of Industry and Information Technology for our company's professional ability, technical ability and innovation ability. It is also about adhering to "specialization.

The affirmation of the new "development path" and the continuous improvement of core competitiveness is an important milestone in the development process of the enterprise.

What is "specialized and new"?

★ Specialization: The use of special technology or process through specialized production of professional products.

★ Fine: Through fine management, according to the fine and efficient management system and process to produce excellent products.

★ Characteristic: with unique technology, technology, formula or raw materials developed and produced, with regional characteristics or unique functions of the product.

★ Novelization: high-tech products with independent intellectual property rights developed and produced through independent innovation and transformation of scientific and technological achievements.

Cultivating "specialized and new" enterprises and improving the quality of enterprise development is an important work mentioned in a number of documents issued by government departments. Especially this year, "specialized and special new" was written into the "Government Work Report of The State Council" for the first time, and the report mentioned: "Focus on cultivating 'specialized and special new' enterprises, and give strong support in terms of capital, talent, and incubation platform construction." Thus, the development of "specialized and special new" enterprises has officially risen to the national strategic level. "Specialized and special" is the only way for the development of enterprises, and it is a new national policy strongly encouraged and supported by the state.

The soul of "specialized and special new" is innovation, and the base is scientific and technological strength. As the world's largest research and development, production and export base of diclofenac products, Dongtai Pharmaceutical has always focused on non-steroidal anti-inflammatory drugs and antiviral drugs series, and has continuously honed its scientific and technological strength for more than 20 years, taking technological innovation as the main driving force for enterprise development. Obtained a number of scientific and technological achievements and patents, among which "Diclofenac antipyretic analgesic drug production key technology research and application" won the "National science and technology Progress Award", 2 provincial science and technology achievements, 2 municipal science and technology achievements; Obtained 44 patents. And has been awarded: national high-tech enterprises, one of the provincial 100 high enterprises, Provincial chiral drug Engineering technology Research center, Provincial Enterprise Technology center, provincial postdoctoral research and development base, export base, Anyang City 50 high enterprises, excellent private enterprises, three consecutive won the China Entry-exit Inspection and Quarantine Association "China Quality integrity Enterprise" honorary titles.

High professionalism and high standardization have always been the development direction of Dongtai Pharmaceutical, and the award of the national "specialized and special new" enterprise is not only an affirmation of the professionalism of Dongtai Pharmaceutical, but also a high recognition of Dongtai's technical strength and innovation ability, which urges us to continue to consolidate the foundation of innovation.

Dong Tai has never stopped exploring the road ahead. In the future, Dongtai will continue to adhere to the quality-oriented, pragmatic innovation, shared growth, responsibility for the business philosophy; To strengthen the enterprise, rich employees, for the well-being of human health for the purpose of the enterprise; To create a first-class team, to build a hundred years of Dongtai for the goal. With "innovation, intelligence, big data" as the business strategy guidance, deep cultivation in the field of non-steroidal raw materials, relying on their own professional and innovative ability, and constantly develop more "specialized special new" products, play a good demonstration role of "specialized special new" enterprises, improve the competitiveness of products, and contribute their greater strength to the technological progress of the pharmaceutical industry.